Idexx Laboratories
IDXX
999 hedge funds and large institutions have $29.8B invested in Idexx Laboratories in 2022 Q4 according to their latest regulatory filings, with 164 funds opening new positions, 330 increasing their positions, 354 reducing their positions, and 66 closing their positions.
148% more first-time investments, than exits
New positions opened: 164 | Existing positions closed: 66
33% more funds holding in top 10
Funds holding in top 10: 18 → 24 (+6)
24% more capital invested
Capital invested by funds: $24B → $29.8B (+$5.83B)
8% more funds holding
Funds holding: 922 → 999 (+77)
0.01% less ownership
Funds ownership: 88.42% → 88.41% (-0.01%)
7% less repeat investments, than reductions
Existing positions increased: 330 | Existing positions reduced: 354
15% less call options, than puts
Call options by funds: $152M | Put options by funds: $178M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$130M |
| 2 |
Morgan Stanley
New York
|
+$101M |
| 3 |
Winslow Capital Management
Minneapolis,
Minnesota
|
+$80.9M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$62.2M |
| 5 |
JP Morgan Chase
New York
|
+$46.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$128M |
| 2 |
BlackRock
New York
|
-$112M |
| 3 |
Fundsmith LLP
London,
United Kingdom
|
-$68.7M |
| 4 |
Principal Financial Group
Des Moines,
Iowa
|
-$60.6M |
| 5 |
DDC
DF Dent & Co
Baltimore,
Maryland
|
-$57M |
IDXX Hedge Fund Activity: Q4 2022 in Review
999 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q4 2022, worth a combined $29.8B — up 24% from $24B a quarter earlier.
Buyers outnumbered sellers: 164 funds opened new IDXX positions and 66 closed out — a net gain of 98 holders — while 330 added to existing stakes and 354 trimmed.
The largest buyer was AllianceBernstein, adding an estimated $130M. The largest seller was Fidelity Investments, cutting an estimated $128M.
- 999 institutional investors held Idexx Laboratories (IDXX) as of Q4 2022, up from 922 in Q3 2022.
- Funds reported $29.8B of Idexx Laboratories stock for Q4 2022, up 24% quarter-over-quarter.
- 164 funds opened new Idexx Laboratories positions in Q4 2022 and 66 closed out, a net change of +98 holders.
- The largest Idexx Laboratories buyer in Q4 2022 was AllianceBernstein, an estimated $130M added.
- The largest Idexx Laboratories seller in Q4 2022 was Fidelity Investments, an estimated $128M sold.
Based on aggregated 13F filings for Q4 2022.